Antitrypanosomal activity & docking studies of isolated constituents from the lichen Cetraria islandica: Possibly multifunctional scaffolds

Current Topics in Medicinal Chemistry

Volumn 14, Issue 8, 2014, Pages 1014-1021

  Igoli, John Ogbaji ^a   Gray, Alexander Irvine ^a   Clements, Carol Jean ^a   Kantheti, Poorna ^a   Singla, Rajeev Kumar ^b  

^a UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^b NETAJI SUBHAS INSTITUTE OF TECHNOLOGY   (India)

Author keywords

Antitrypanosomal activity; Cetraria islandica; Grip docking; Iceland moss; Phytoconstituents

Indexed keywords

FUMARPROTOCETRARIC ACID; GLUTATHIONE SYNTHASE; LICHESTERINIC ACID; PLANT MEDICINAL PRODUCT; PROTOCETRARIC ACID; PROTOLICHESTERINIC ACID; RIBOFLAVIN KINASE; ROHEDSAIN; STEROL 14ALPHA DEMETHYLASE; SURAMIN; UNCLASSIFIED DRUG; ANTITRYPANOSOMAL AGENT;

AFRICAN TRYPANOSOMIASIS; ANTIPROTOZOAL ACTIVITY; ANTITRYPANOSOMAL ACTIVITY; ARTICLE; BINDING SITE; CARBON NUCLEAR MAGNETIC RESONANCE; COLUMN CHROMATOGRAPHY; CONTROLLED STUDY; DRUG EFFICACY; DRUG SCREENING; EXTRACTION; HYDROPHOBICITY; LICHEN (ORGANISM); LICHEN ISLANDICUS; MELTING POINT; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR DOCKING; MOLECULAR INTERACTION; NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE; TRYPANOSOMA BRUCEI; CHEMICAL STRUCTURE; CHEMISTRY; DRUG EFFECTS; MICROBIAL SENSITIVITY TEST; STRUCTURE ACTIVITY RELATION; TRYPANOSOMA BRUCEI BRUCEI;

LICHENS; MICROBIAL SENSITIVITY TESTS; MOLECULAR STRUCTURE; STRUCTURE-ACTIVITY RELATIONSHIP; TRYPANOCIDAL AGENTS; TRYPANOSOMA BRUCEI BRUCEI;

EID: 84903722768     PISSN: 15680266     EISSN: 18734294     Source Type: Journal    
DOI: 10.2174/1568026614666140324122323     Document Type: Article

References (29)

1. Dua, V.K.; Verma, G.; Dash, A.P. In vitro antiprotozoal activity of some xanthones isolated from roots of Andrographis paniculata. Phytother. Res., 2009, 23, 126-128.
2. Aggarwal, B.; Ali, M.; Singh, V.; Singla, R.K. Isolation and characterization of phytoconstituents from the stem of Ichnocarpus frutescens. Chin. J. Nat. Med., 2010, 8, 401-404.
3. Herrmann, F.; Sporer, F.; Tahrani, A.; Wink, M. Antitrypanosomal properties of Panax ginseng C.A. meyer: new possibilities for a remarkable traditional drug. Phytother. Res., 2013, 27, 86-98.
4. Igoli, N.P.; Gray, A.I.; Clements, C.J.; Igoli, J.O.; Nzekwe, U.; Singla, R.K. Scientific investigation of antitrypansomal activity of Crateva adansonii DC leaves extracts. Indo Global J. Pharm. Sci., 2012, 2, 226-229.
5. Bown, D. Encyclopedia of Herbs and their Uses. London: Dorling Kindersley, 2001.
6. Chevallier, A. The Encyclopedia of Medicinal Plants. New York: Dorling Kindersley, 1996.
7. Malhotra, S.; Subban, R.; Singh, A.P. Lichens- role in traditional medicine and drug discovery. The Internet Journal of Altern. Medicine, 2008, 5, 2.
8. Vartia, K.O. Antibiotics in lichens. In; Ahmadjian, V., Hale, M. E., Eds.; New York: The Lichens Academic Press Inc, 1973; pp. 547-561.
9. Culberson, C.F.; Culberson, W.L.; Johnson, A. Second supplement to Chemical and botanical guide to lichen products. St. Louis: American Bryological and Lichenological Society, Missouri Botanical Garden, 1977.
10. Ingolfsdottir, K. Usnic acid. Phytochemistry, 2002, 61, 729-736.
11. Ingolfsdottir, K.; Hjalmarsdottir, M.A.; Sigurdsson, A.; Gudjons-dottir, G.A.; Brynjolfsdottir, A.; Steingrimsson, O. In vitro susceptibility of Helicobacter pylori to prolichesterinic acid from the lichen Cetraria islandica. Antimicrob. Agents Chemother., 1997, 41, 215-217.
12. Horhant, D.; Lamer, A-C.L.; Boustie, J.; Uriac, P.; Gouault, N. Separation of a mixture of paraconic acids from Cetraria islandica (L.) Ach. employing a fluorous tag-catch and release strategy. Tetrahedron Lett., 2007, 48, 6031-6033.
13. Krivoshchekova, O.E.; Maximov, O.B.; Stepanenko, L.S.; Mish-chenko, N.P. The Bryolichenological Investigations in the U.S.S.R., Kolsky branch of the Academy of Sciences of the U.S.S.R., 1986.
14. Takahata, H.; Uchida, Y.; Momose, T. Concise Syntheses of natural gamma-butyrolactones, (+)-trans-whisky lactone, (+)-trans-cognac lactone, (-)-methylenolactocin, (+)-nephrosteranic Acid, and (+)-roccellaric acid using novel chiral butenolide synthons. J. Org. Chem., 1995, 60, 5628 5633.
15. Bezivin, C.; Tomasi, S.; Rouaud, I.; Delcros, J.G.; Boustie, J. Cyto-toxicity activity of compounds from the lichen: Cladonia convo-luta. Planta Med., 2004, 70, 874-877.
16. Lohezic-Le, D.F.; Tomasi, S.; Elix, J.A.; Bernard, A.; Rouaud, I.; Uriac, P.; Boustie, J. Stictic acid derivatives from the lichen Usnea articulata and their antioxidant activities. J. Nat. Prod., 2007, 70, 1218-1220.
17. Buckner, F.S.; Bahia, M.T.; Suryadevara, P.K.; White, K.L.; Shackleford, D.M.; Chennamaneni, N.K.; Hulverson, M.A.; Laydbak, J.U.; Chatelain, E.; Scandale, I.; Verlinde, C.L.; Char-man, S.A.; Lepesheva, G.I.; Gelb, M.H. Sterol-14a-demethylase(CYP51) from Trypanosoma brucei in complex with tipifarnib derivative 6-((4-chlorophenyl)(methoxy)(1 -methyl- 1H-imidazol-5-yl)methyl)-4-(2,6-difluorophenyl)-1-methylquinolin-2(1H)-one. Antimicrob. Agents Chemother., 2012, 56, 4914-4921.
18. Fyfe, P.K.; Alphey, M.S.; Hunter, W.N. Structure of trypanosome brucei glutathione synthetase: domain and loop alterations in the catalytic cycle of a highly conserved enzyme. Mol. Biochem. Para-sitol, 2010, 170, 93.
19. Merritt, E.A.; Holmes, M. Riboflavin kinase from Trypanosoma brucei. Submitted (DEC-2007) to the PDB data bank. DOI: 10.2210/pdb3bnw/pdb.
20. Marrion, R.; Hansell, E.; Caffrey, C; Roush, W.R.; Brinen, L.S. The high resolution crystal structure of rohedsain, the major cathepsin L protease from T. brucei rhodesiense, bound to inhibitor K11002. Submitted (MAR-2007) to the PDB data bank. DOI: 10.2210/pdb2p86/pdb
21. Patterson, S.; Alphey, M.S.; Jones, D.C.; Shanks, E.J.; Street, I.P.; Frearson, J.A.; Wyatt, P.G.; Gilbert, I.H.; Fairlamb, A.H. Dihydro-quinazolines as novel class of Trypanosoma brucei trypanothione reductase inhibitors: Discovery, synthesis, and characterization of their binding mode by protein crystallography. J. Med. Chem., 2011, 54, 6514.
22. Bhuva, H.A.; Kini, S.G. Synthesis, anticancer activity and docking of some substituted benzothiazoles as tyrosine kinase inhibitor. J. Mol. Graphics Modell., 2010, 29, 32-37.
23. Malleshappa, N.N.; Patel, H.M. A comparative QSAR analysis and molecular docking studies of quinazoline derivatives as tyrosine kinase (EGFR) inhibitors: A rationale approach to anticancer drug design. J. Saudi Chem. Soc., 2013, 17, 361-379.
24. Singla, R.K.; Bhat, V.G. QSAR model for predicting the fungicidal action of 1,2,4-triazole derivatives against candida albicans. J. Enzyme Inhib. Med. Chem., 2010, 25, 696-701.
25. VLifeMDS: Molecular Design Suite. VLife Sciences Technologies Pvt. Ltd., Pune, India, 2010. URL: www.vlifesciences.com/
26. Murta, M.M.; Azavedo, M.B.M.; Greene, A.E. Synthesis and absolute stereochemistry of (-)-protolichesterinic acid, antitumor antibiotic lactone from Cetraria islandica. J. Org. Chem., 1993, 58, 7536-7537.
27. Patel, R.M.; Argade, N.P. General approach to 2,4-dialkyl-3-carboxybutyrolactones: An efficient synthesis of (±)-striatisporolide A and (±)-lichesterinic acid. Ind. J. Chem., 2010, 49B, 1071-1075.
28. Su, B.N.; Cuendet, M.; Nikolic, D.; Kristinsson, H.; Ingolfsdottir, K.; Breemen, R.B.V.; Fong, H.H.S.; Pezzuto, J.M.; Kinghorn, A.D. NMR study of fumarprotocetraric acid, a complex lichen depsidone derivative from Cladonia furcata. Magn. Reson. Chem., 2003, 41, 391-394.
29. Steverding, D.; Tyler, K.M. Novel antitrypanosomal agents. Expert Opin. Investig. Drugs, 2005, 14, 939-955.